• Company
• Samsung Bioepis’ 3mth operating profit exceeds last year's
• by Chon, Seung-Hyun Jul 26, 2024 05:47am

• Company
• "Active viral hepatitis treatment can prevent carcinoma"
• by Son, Hyung-Min Jul 26, 2024 05:47am

• Company
• Mitsubishi accepts DREC results for Uplizna...nears reimb
• by Eo, Yun-Ho Jul 26, 2024 05:47am

• Company
• Guidelines for new obesity drugs must be established
• by Moon, sung-ho Jul 26, 2024 05:46am

• Company
• Antibiotic prescriptions had surged with the pandemic
• by Kim, Jin-Gu Jul 25, 2024 05:51am

• Company
• Meningitis B vaccine Bexsero is released in Korea
• by Moon, sung-ho Jul 25, 2024 05:51am

• Company
• 'Padcev+Keytruda' combination therapy is set to land in KOR
• by Eo, Yun-Ho Jul 25, 2024 05:51am

• Company
• Samsung Bioepis’ Soliris biosimilar is approved in the U.S.
• by Chon, Seung-Hyun Jul 24, 2024 05:51am

• Company
• Reimb applied for new HIV drug 'Vocabria+Rekambys'
• by Eo, Yun-Ho Jul 24, 2024 05:50am

• Company
• Will 'Zejula' be reimbursed for HRD-positive ovarian cancer?
• by Eo, Yun-Ho Jul 23, 2024 05:48am